NASDAQ:DFTX | Cash Flow Statement | Definium Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$158.99M
2026-03-31-$77.1M-$42.63M$42M$5.31M
2025-12-31-$50.44M-$42.98M$34.98M$245.87M
2025-09-30-$67.27M
2025-06-30-$42.74M
2025-03-31-$23.35M-$29.42M-$162.46M$1M
2024-12-31-$34.74M-$25.35M$0.00$3.81M
2024-09-30-$13.68M
2024-06-30-$5.85M
2024-03-31-$54.4M-$16.6M$0.00$169.25M
2023-12-31-$23.86M-$20.56M$2.59M
2023-09-30-$17.92M
2023-06-30-$29.13M
2023-03-31-$24.82M-$13.33M$583,000.00
2022-12-31-$4.9M-$12.85M$416,000.00
2022-09-30-$16.49M
2022-06-30-$16.96M
2022-03-31-$18.45M-$12.87M-$166,000.00
2021-12-31-$16.83M-$7.83M$113,000.00$127,000.00
2021-09-30-$17.2M
2021-06-30-$45.25M
2021-03-31-$13.76M-$10.04M-$316,000.00$89.99M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$183.79M-$131.56M-$151.61M$267.27M
2024-12-31-$108.68M-$79.13M$0.00$253.2M
2023-12-31-$95.73M-$64.37M$21.85M
2022-12-31-$56.8M-$50.14M$59.05M
2021-12-31-$93.04M-$45.82M-$297,000.00$98.82M
2020-12-31-$33.94M-$23.6M$96.7M